Fixed-Duration Pirtobrutinib Combined with Venetoclax Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results, Including MRD Data, from the BRUIN Phase 1b StudyLindsey E. Roeker,Jennifer A. Woyach,Chan Y. Cheah,Catherine C. Coombs,Nirav N. Shah,William G. Wierda,Manish Patel,Donald E. Tsai,Binoj Nair,Chunxiao Wang, Xiang Zhao, Narasimha Marella,Caleb Ho,Samuel McNeely,Jennifer R. BrownBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
